We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

85 hedge funds and large institutions have $110M invested in Fortress Biotech in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $101M → $110M (+$9.15M)

0.05% less ownership

Funds ownership: 2.27% → 2.23% (-0.05%)

4% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 28

2% less funds holding

Funds holding: 87 → 85 (-2)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders
85
Holders Change
-2
Holders Change %
-2.3%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
27
Reduced
28
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.16M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$894K
3
BlackRock
BlackRock
New York
+$516K
4
Prudential Financial
Prudential Financial
New Jersey
+$481K
5
PCM
Perkins Capital Management
Minnesota
+$479K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$2.32M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.68M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$775K
4
6CM
683 Capital Management
New York
-$635K
5
SC
Sepio Capital
Utah
-$427K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
51
State Board of Administration of Florida Retirement System
Florida
$79K – – –
Millennium Management
52
Millennium Management
New York
$71K -$2.32M -41,043 -97%
DY
53
Dowling & Yahnke
California
$71K – – –
CS
54
Candriam SCA
Luxembourg
$68K – – –
ProShare Advisors
55
ProShare Advisors
Maryland
$63K +$11.5K +204 +21%
Invesco
56
Invesco
Georgia
$60K +$13K +230 +25%
UBS Group
57
UBS Group
Switzerland
$58K +$4.96K +88 +9%
Principal Financial Group
58
Principal Financial Group
Iowa
$48K -$8.07K -143 -14%
TRCT
59
Tower Research Capital (TRC)
New York
$48K +$16.6K +294 +48%
WP
60
WMS Partners
Maryland
$41K – – –
CSS
61
Cubist Systematic Strategies
Connecticut
$41K +$43.9K +778 New
Victory Capital Management
62
Victory Capital Management
Texas
$40K -$4.29K -76 -9%
GIA
63
Gladstone Institutional Advisory
Florida
$39K – – –
SAG
64
Spotlight Asset Group
Illinois
$38K +$40.2K +713 New
BNP Paribas Financial Markets
65
BNP Paribas Financial Markets
France
$30.8K -$17K -301 -34%
PAM
66
Panagora Asset Management
Massachusetts
$30K -$1.52K -27 -5%
Osaic Holdings
67
Osaic Holdings
Arizona
$25K – – –
Legal & General Group
68
Legal & General Group
United Kingdom
$24K -$142K -2,516 -85%
Citigroup
69
Citigroup
New York
$24K -$29.9K -530 -53%
EWM
70
Edge Wealth Management
New York
$21K – – –
AIP
71
Ameritas Investment Partners
Nebraska
$18K – – –
SPIA
72
Steward Partners Investment Advisory
New York
$17.6K +$18.8K +333 New
Royal Bank of Canada
73
Royal Bank of Canada
Ontario, Canada
$17K -$2.14K -38 -10%
CG
74
Cutler Group
California
$14K – – –
Bank of Montreal
75
Bank of Montreal
Ontario, Canada
$10K -$31.8K -563 -80%
1 2
3
4

FBIO Hedge Fund Activity: Q1 2021 in Review

85 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2021, worth a combined $110M — up 9% from $101M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of FBIO and 7 opened new positions — a net loss of 2 holders — while 28 trimmed existing stakes and 27 added.

The largest buyer was Vanguard Group, adding an estimated $2.16M. The largest seller was Millennium Management, cutting an estimated $2.32M.

  • 85 institutional investors held Fortress Biotech (FBIO) as of Q1 2021, down from 87 in Q4 2020.
  • Funds reported $110M of Fortress Biotech stock for Q1 2021, up 9% quarter-over-quarter.
  • 7 funds opened new Fortress Biotech positions in Q1 2021 and 9 closed out, a net change of -2 holders.
  • The largest Fortress Biotech buyer in Q1 2021 was Vanguard Group, an estimated $2.16M added.
  • The largest Fortress Biotech seller in Q1 2021 was Millennium Management, an estimated $2.32M sold.

Based on aggregated 13F filings for Q1 2021.